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Elevated prevalence of Helicobacter
species and virulence factors in
opisthorchiasis and associated
hepatobiliary disease
Raksawan Deenonpoe1,2,†, Eimorn Mairiang3, Pisaln Mairiang4, Chawalit Pairojkul2,
Yaovalux Chamgramol2, Gabriel Rinaldi5,‡, Alex Loukas6, Paul J. Brindley5 & Banchob Sripa1,2
Recent reports suggest that Opisthorchis viverrini serves as a reservoir of Helicobacter and implicate
Helicobacter in pathogenesis of opisthorchiasis-associated cholangiocarcinoma (CCA). Here, 553 agesex matched cases and controls, 293 and 260 positive and negative for liver fluke O. viverrini eggs, of
residents in Northeastern Thailand were investigated for associations among infection with liver fluke,
Helicobacter and hepatobiliary fibrosis. The prevalence of H. pylori infection was higher in O. viverriniinfected than uninfected participants. H. pylori bacterial load correlated positively with intensity of
O. viverrini infection, and participants with opisthorchiasis exhibited higher frequency of virulent
cagA-positive H. pylori than those free of fluke infection. Genotyping of cagA from feces of both infected
and uninfected participants revealed that the AB genotype accounted for 78% and Western type 22%.
Participants infected with O. viverrini exhibited higher prevalence of typical Western type (EPIYA
ABC) and variant AB’C type (EPIYT B) CagA. Multivariate analyses among H. pylori virulence genes and
severity of hepatobiliary disease revealed positive correlations between biliary periductal fibrosis during
opisthorchiasis and CagA and CagA with CagA multimerization (CM) sequence-positive H. pylori. These
findings support the hypothesis that H. pylori contributes to the pathogenesis of chronic opisthorchiasis
and specifically to opisthorchiasis-associated CCA.
Infection with the fish-borne liver fluke Opisthorchis viverrini is endemic in Southeast Asia including regions of
the Lao People’s Democratic Republic, Thailand, Cambodia and Vietnam1–3. Opisthorchiasis is associated with
hepatobiliary morbidity including chronic cholangitis, cholelithiasis, periductal fibrosis and bile duct cancer, or
cholangiocarcinoma (CCA)4–7. Khon Kaen province in Northeast Thailand has reported the highest incidence of
CCA in the world, greater than 100 cases per 100,000 residents8. Chronic inflammation in response to metabolites
and growth factors released by this parasitic worm and related phenomena are implicated in the pathogenesis of
liver fluke infection-associated hepatobiliary diseases7,9–12. However, the biliary morbidity in the setting of opisthorchiasis may not be solely linked with liver fluke infection; other factors including carriage of Helicobacter and
other microbiome changes within the biliary tract might participate13.
More than 30 species of Helicobacter have been described14 and H. pylori was the first bacterial pathogen
confirmed to cause gastric disease including peptic ulcer, gastric lymphoma and gastric adenocarcinoma15–19. On
the other hand, carriage of H. pylori occurs in at least half the human population with transmission from mother
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Negative for
O. viverrini

Positive for
O. viverrini

H. pylori + ve
(n = 267)

H. bilis + ve
(n = 99)

H. hepaticus + ve
(n = 18)

49 ±  9·6

49·6 ±  9·4

48·7 ±  10·4

49 ±  10·3

53 ±  10

Female

135/260 (51·9%)

153/293 (52·2%)

129 (48·3%)

48 (48%)

10/18 (55·6%)

Male

125/260 (48·1%)

140/293 (47·8%)

138 (51·7%)

52 (52%)

8/18 (44·5%)

0·38

0·28

0·44

0·57

0·51

Characteristic
Age in years
(mean ±  SD)
Gender

P

Table 1. Gender and age of participants and status of infection with Opisthorchis viverrini and species of
Helicobacter.

Figure 1. Prevalence of Helicobacter species, H. pylori, H. bilis, H. hepaticus and mixed H. pylori and
H. bilis in participants who were either uninfected or infected with Opisthorchis viverrini.

to child and other routes. Indeed the human-H. pylori association likely is at least 100,000 years old20, an association that appears to be beneficial in early life, including contributions to a healthy microbiome and reduced
early-onset asthma21,22. Infection with species of Helicobacter has been implicated in other malignant and benign
diseases of the biliary tract23–28. Virulence factors of H. pylori including cytotoxin-associated gene A (cagA), cagE
and vacuolating cytotoxin A (vacA) participate in the pathogenesis of these conditions29. The related species
H. hepaticus and H. bilis also associate with hepatobiliary diseases30–32.
Opisthorchiasis may enhance colonization of the biliary tree by species of Helicobacter in like fashion to other
changes in the biliary microbiome33. The influence of opisthorchiasis on cholestasis as a consequence of the liver
fluke migration and establishment within the bile ducts provide explanations for bacterial colonization leading
to bacterial cholangitis34. In addition, the migration of the flukes themselves from the external environmental
through the alimentary tract and into the biliary tract might convey bacterial passengers, both on the external
surface of the trematode and within the gut of the parasite35–38.
We recently reported, in a hamster model of liver fluke infection-induced biliary disease, higher prevalence
and intensity of co-infection with H. pylori and H. bilis in O. viverrini-infected compared to uninfected hamsters,
suggesting that this liver fluke serves as a reservoir for H. pylori37. Here we undertook a human study with more
than 500 residents in villages of four provinces of northeastern Thailand endemic for opisthorchiasis3. Liver fluke
infection was associated with a higher frequency of cagA-positive H. pylori. Moreover, the presence of H. pylori
cagA gene as well as its alleles was associated with increased morbidity, specifically periductal fibrosis of the
biliary tree. These findings support the hypothesis that H. pylori contributes to the pathogenesis of chronic opisthorchiasis and specifically to opisthorchiasis-associated cholangiocarcinoma.

Results

Liver fluke burden positively correlated with Helicobacter infection. The distribution of infection
with Helicobacter spp. in regions endemic for opisthorchiasis was established according to age, gender, burden of
liver fluke, as diagnosed fecal EPG and ultrasonography score for hepatobiliary disease including fibrosis. A total
of 553 residents from four provinces of Thailand participated in the study; samples of feces from 260 participants
were egg negative whereas 293 were positive for eggs of O. viverrini (Table 1).
In addition to infection with O. viverrini, analysis of feces by PCR was used to investigate the presence of
Helicobacter spp. A total of 267 participants of four Isaan provinces of Thailand were positive for H. pylori, 99 for
H. bilis and 18 for H. hepaticus. Gender did not correlate with presence of species of Helicobacter, P > 0·05
(Table 1).
The prevalence of infection with H. pylori assigned as ureA gene-positive by stool PCR was 64·6% vs. 29·6% in
O. viverrini-infected and uninfected participants, respectively; P < 0·01. The prevalence of infection with H. bilis,
but not H. hepaticus, was also significantly higher in O. viverrini-infected vs. uninfected individuals, 29·3 vs 5·4%,
P < 0·01. In addition, mixed H. pylori/H. bilis infection was significantly higher during infection with O. viverrini:
26·9% compared to participants who were stool-negative for O. viverrini, 4·2%, P <  0·01 (Fig. 1).
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EPG O. viverrini
Level of infection intensity
16 S rRNA

0

1–100

101–500

501–1,000

(n = 260)

(193)

(73)

(12)

(15)

125 (48·1%)

135 (69·6%)

62 (84·9%)

11 (91·7%)

15 (100%)
NA

>1,000

OR

1

2·51

6·09

11·88

95% CI

—

1·69–3·72

3·06–12·09

1·51–93·36

NA

P

—

<0·001

<0·001

0·003

<0·001

77 (29·6%)

110 (57%)

57 (78·1%)

10 (83·3%)

13 (86·7%)

1

3·14

8·47

11·88

15·45

95% CI

—

2·13–4·65

4·58–15·66

2·54–55·51

3·40–70·09

P

—

<0·001

<0·001

<0·001

<0·001

14 (5·4%)

45 (23·3%)

23 (31·5%)

7 (58·3%)

10 (66·7%)

OR

1

5·34

2·36

24·6

35·14

95% CI

—

2·84–10·07

1·18–4·72

6·92–87·39

10·57–116·80

P

1

<0·001

0·02

<0·001

<0·001

5 (1·9%)

3 (1·6%)

5 (6·8%)

2 (16·7%)

3 (20%)

1

0·81

3·75

10·2

12·75

95% CI

—

0·19–3·41

1·06–13·33

1·76–59·13

2·72–59·71

P

—

0·53

0.04

0·03

0·006

11 (4·2%)

40 (20·7%)

23 (31·5%)

6 (50%)

10 (66·7%)

OR

1

5·92

10·41

22·63

45·27

95% CI

—

2·95–11·88

4·77–22·71

6·27–81·63

13·21–155·16

P

—

<0·001

<0·001

<0·001

<0·001

13 (5·0%)

21 (10·9%)

26 (35·6%)

6 (50%)

9 (60%)

1

2·32

10·51

19·0

28·5

95% CI

—

1·13–4·76

5·04–21·92

15·38–67·09

8·81–92·19

P

—

0·02

<0·001

<0·001

<0·001

7 (2·7%)

13 (6·7%)

16 (21·9%)

3 (25%)

5 (33%)

OR

1

2·61

10·15

12·05

18·07

95% CI

—

1·02–6·67

3·99–25·80

2·67–54·38

4·87–66·9

P

—

0·04

<0·001

0·007

<0·001

1 (0·4%)

9 (4·7%)

12 (16·4%)

3 (25%)

5 (33%)

OR

1

12·7

50·95

86·33

129·5

95% CI

—

1·59–100·86

6·5–399·37

8·16–913·23

13·81–1214·18

P

—

0·003

<0·001

<0·001

<0·001

ureA H. pylori†
OR

H. bilis†

H. hepaticus
OR

H. pylori +  H. bilis†

cagA†
OR

cagE†

cagA +  cagE†

P for trend

0·06
<0·001

<0·001

P =  0·08

<0·001

<0·001

<0·001

<0·001

Table 2. Prevalence of Helicobacter spp. and virulence factors in study participants, presented for
each of five levels of intensity of infection with Opisthorchis viverrini. P = P-value, OR =  Odds Ratio,
CI = Confidence Interval. The reference group for the analysis and to estimate P-values and RRR is the
uninfected i.e. group, EPG O. viverrini = 0, where the OR is 1.

Increased prevalence and load of H. pylori and H. bilis during opisthorchiasis.

The mass of H.
pylori in one-gram of feces correlated positively with the intensity of liver fluke infection (one-way ANOVA,
P < 0·001) (Supplementary Figure S1). In general, participants with higher intensity infection (>1,000 EPG) had
~15 times the total cell counts of H. pylori compared those who were negative for infection with O. viverrini
(EPG = 0). Load of H. pylori increased according to intensity of liver fluke infection; P < 0·001 for each sequential
comparison (Supplementary Figure S1).
The positive relationship between Helicobacter and O. viverrini infection was substantiated by positive correlations between 16 S rRNA and intensity of liver fluke infection (χ2 =  0·06), ureA (H. pylori) and intensity of liver
fluke infection (χ2 trend <  0·001), cagA and intensity of liver fluke infection (χ2 trend <  0·001), cagE and intensity
of liver fluke infection (χ2 trend <  0·001), and H. bilis and intensity of liver fluke infection (χ2 trend <  0·001);
but not for H. hepaticus. Generally, the presence of H. pylori and H. bilis was far higher during elevated levels of
infection with O. viverrini than during low intensity infections or in the uninfected participants. Table 2 details
the findings.

Helicobacter spp. associated with grade of biliary peridcutal fibrosis.

The presence of cagA was
associated with an elevated risk of both grade 2 and grade 3 biliary periductal fibrosis. The relative risk ratio
(RRR) for grade 2 versus grade 1 or 0 hepatobiliary disease was 3·38 (95% C1·51–7·58, P =  0·003) comparing
individuals with and without cagA, in the model adjusted for age and sex (Table 3). The analogous RRR was 9·15
for grade 3 vs. grade 1 or 0 hepatobiliary disease (95% CI 1·74–47·97, P = 0·009) (Table 3). After confirming the
proportional odds assumption, we determined and overall odds ratio of 4·24 for each subsequent grade of hepatobiliary disease comparing individuals with and without cagA, controlling for age and sex; P <  0·001.
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Helicobacter

Grade 0 + 1 (n = 241)

Grade + 2 (n = 36)

Grade + 3 (n = 16)

179 (74·3%)

30 (83·3%)

13 (81·3%)

16 S rRNA Helicobacter
species
RRR

1

1·62

1·63

95% CI

—

0·64–4·11

0·43–6·24

P
ureA H. pylori

—

0·307

0·476

153 (90%)

28 (90·32%)

8 (100%)

RRR

1

1·03

NA

95% CI

—

0·28–3·75

NA

P
cagA

—

0·969

0·991

39 (25·32%)

16 (53·33%)

6 (75%)

RRR

1

3·38

9·15

95% CI

—

1·51–7·58

1·75–47·97

P
cagE

—

0·003

0·009

26 (61·9%)

7 (43·75%)

5 (83·33%)

RRR

1

0·44

3·30

95% CI

—

0·13–1·52

0·33–32·89

P
cagA +  cagE

—

0·195

0·311

21 (8·71%)

5 (13·89%)

5 (31·25%)

RRR

1

1·69

4·96

95% CI

—

0·59–4·83

1·50–16·35

P
H. bilis

—

0·331

0·009

64 (35·75%)

14 (45·16%)

7 (53·85%)

RRR

1

1·48

2·15

95% CI

—

0·68–3·21

0·68–6·75

P
H. hepaticus

—

0·319

0·191

12 (7·23%)

2 (7·41%)

1 (9·09%)

RRR

1

1·20

1·09

95% CI

—

0·25–5·82

0·12–9·70

P
H. pylori +  H. bilis

—

0·823

0·937

59 (24·38%)

14 (38·89%)

6 (37·50%)

RRR

1

1·95

1·96

95% CI

—

0·93–4·06

0·66–5·79

P

—

0·076

0·223

Table 3. Prevalence of Helicobacter species and virulence genes during infection with Opisthorchis
viverrini, and relationships with status (grade) of hepatobiliary disease as established by abdominal
ultrasonography for degree of periportal echoes. Bold type letters denote significant differences. NA =  not
applicable, RRR = relative risk ratio, P =  P-value, CI = Confidence Interval. The reference group for RRR is
Grade 0 + 1 as grade 0 is baseline negative periductal fibrosis. Some participants were grade 1.

Also, a strong, positive association was evident between the presence of mixed cagA and cagE and marked
hepatobiliary disease; RRR = 4·96 for grade 3 vs. grade 1 or 0, 95% CI =  1·50–16·34, P =0·009. Association was
not evident between positivity for mixed cagA and cagE and grade 2-biliary periductal fibrosis. Associations
between the presence of H. pylori, H. bilis, H. hepaticus alone or in combination with hepatobiliary disease were
not significant

cagA genotypes associated with biliary periductal fibrosis.

In order to categorize the cagA genotypes, sequence analysis was undertaken on cagA-positive samples. Seventy-seven cagA strains were Western
CagA type and unclassified type, AB type. The predominant CagA types were EPIYA-AB type, EPIYA-ABC type
and EPIYA-AB’C type (B’ =  EPIYT)39. Participants who were not infected with O. viverrini showed higher frequency of EPIYA-AB type than did the infected participants, 86·7% vs. 75·8%, respectively (Table 4). On the other
hand, O. viverrini-infected participants carried a marginally higher frequency of EPYA-ABC type (8·1 vs. 6·7%)
and twice as high frequency of EPIYA-AB’C (16·1 vs. 6·7%) (Table 4). In overview, the Western type CagA with
EPIYA-AB’C showed higher frequency in the liver fluke-infected cases.
In addition, some cagA genotypes included the CagA multimerization (CM) motif. CM is comprised of 16
amino acids, FPLKRYDKFDDLSKVG or FPLKRHDKFDDLSKVG and is highly conserved for Western and
Eastern CagA40,41. Whereas the prevalence of CagA with CM in EPIYA-AB type was 30·8–36·2% in liver fluke
infection-negative and -positive participants, respectively, CM was present in all (100%) of the EPIYA-ABC and
EPIYA-AB’C (EPIYT) genotypes detected (Table 5).
Concerning associations between CagA types and grade of biliary periductal fibrosis, significant associations
between AB’C type versus AB type and both grade 2 (RRR = 23·12, 95% CI =  2·31–23·50, P = 0·007, and grade
Scientific Reports | 7:42744 | DOI: 10.1038/srep42744
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Negative for
O. viverrini (%)

Positive for
O. viverrini (%)

EPIYA-AB TYPE*

13/15 (86·7)

47/62 (75·8)

EPIYA-ABC TYPE

1/15 (6·7)

5/62 (8·1)

EPIYA-AB’C TYPE
(B’ =  EPIYT)

1/15 (6·7)

10/62 (16·1)

15

62

Genotype

Total

Table 4. Associations among genotypes of CagA of Helicobacter pylori and infection status with
Opisthorchis viverrini.

Negative for
O. viverrini (%)

Positive for
O. viverrini (%)

Total (%)

4/13 (30·8)

17/47 (36·2)

21/60 (35)

EPIYA-ABC

1/1 (100)

5/5 (100)

6/6 (100)

EPIYA-AB’C TYPE
(B’ =  EPIYT)†

1/1 (100)

10/10 (100)

11/11 (100)

Genotype
EPIYA-AB TYPE

Table 5. Associations among cagA genotypes bearing the CagA multimerization motif (CM) and infection
with Opisthorchis viverrini.

Helicobacter

Grade 0 + 1
n = 242

Grade + 2
n = 36

Grade + 3
n = 16

cagA genotype

40 (16·6%)

12 (40%)

3 (23·1%)

1

1·27*

2·31*

23·12**

24·36**

RRR
95% CI
P
cagA CM
sequence

—
—

11 (26·8%)

0·21–7·61

0

2·32–230·5

1·71–347·09

0·794*

0·994*

0·007**

0·018**

16 (88·9%)

6 (100%)
1·41

RRR

1

30·74

95% CI

—

5·25–180·08

0

P

—

<0·001

0·99

Table 6. CagA genotypes in participants positive for liver fluke infection, and relationships with status
(grade) of biliary periductal fibrosis as established by abdominal ultrasonography. *ABC type; **AB’C type;
RRR, relative risk ratio; P =  P-value; CI, confidence interval. Boldface type highlights significant differences.

3 (RRR = 24·36, 95% CI =  1·71–347·09, P = 0·018) were apparent (Table 6). There was no association between
ABC type versus AB type and hepatobiliary disease. In addition, regarding CagA types with or without the CM
sequence, significant association between CagA with CM sequence and grade 2 was evident (RRR =  30·74, 95%
CI =  5·25–180·08, P < 0·001). After confirming the proportional odds assumption, we determined an overall odds
ratio of 30·8 for each subsequent grade of biliary periductal fibrosis comparing individuals carrying CagA with
and without the CM sequence, and controlling for age and sex (P < 0·001). Similarly, after grouping the degree
of hepatobiliary disease as either negative (grades 0 + 1) or positive (grades 2 + 3), as described42,43, a significant association was apparent between positive for hepatobiliary disease and CagA with CM sequence with an
odds ratio of 38·21 (95% CI =  6·85–213·03, P < 0·001). On the other hand, the wide range for CI in this analysis
reflected the limited number of cases in the dataset due to this uncommon genotype and, in turn, the limited
power of this analysis.

Phylogram analysis of CagA EPIYA motifs revealed novel genotypes during liver fluke infection.

The phylogenetic relationships of CagA genotypes among 75 samples from this cohort of participants from northeastern Thailand, specifically 13 negative and 62 positive for infection with O. viverrini, were compared with two
Western cagA and two Eastern cagA reference strains detected in gastro-duodenal disease in Thailand, and three
CagA sequences isolated from bile from Thai cholangiocarcinoma (CCA) cases, as reported33,44. The relationships were determined using maximum parsimony. Representative cagA-encoded sequences of our Thai cohort
mainly grouped into main clusters: (1) Unclassified type, EPIYA AB without CM sequence, e.g. samples FPNS105,
FNK3; (2) Unclassified type, EPIYA AB with CM sequence, e.g. FNK9, FNK10; (3) ‘Western-like’ type EPIYA
ABC, e.g. FPK3, FPNS5; and (4) ‘Western-like’ type EPIYA AB’C, e.g. FPK4, FPNS8. By contrast, the sequences

Scientific Reports | 7:42744 | DOI: 10.1038/srep42744
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Figure 2. Phylogenetic relationship among partial CagA sequences amplified from representative
samples. Panel A. Bootstrap consensus phylogenetic tree inferred from 500 replicates revealing four major
clusters; EPIYA AB type without CagA multimerization domain (CM) (blue); EPIYA AB type containing CM
domain (red); EPIYA ABC type ‘Western-like’ (green), and EPIYA AB’C type ‘Western-like’ (purple). Two
Western CagA (W) and two Eastern CagA (E) reference strains detected in gastro-duodenal disease in the
Thailand cohorts, and three CagA sequences isolated from bile from Thai cholangiocarcinoma (CCA) cases42
were included (black). Branches corresponding to partitions reproduced in less than 50% bootstrap replicates
were collapsed; bootstrap numbers higher than 60% are shown. Hepatobiliary disease status and O. viverrini
infection status are shown for each sample following the indicated color code, *for egg-negative O. viverrini
samples no ultrasound study was performed, EPG: eggs per gram of feces. Panel B. Multiple sequence alignment
of representative partial CagA sequences belonging to four major clusters comprising the phylogram. Two
representative sequences of each cluster are color-squared following the same color code as in Panel A. EPIYA
domains are indicated as A, B and C, and CagA multimerization domains (CM) are highlighted (yellow).
of Western, Eastern and CCA cases grouped together, generally divergent from sequences in the present cohort
(Fig. 2). The association between the ‘Western like’ genotypes, including EPIYA AB’C, and the hepatobiliary
pathology is evident for the sequences analyzed in the phylogenetic tree shown in Fig. 2A. Figure 2B depicts
representative sequences that belong to the main clusters of CagA described above, indicating the EPIYA motives
and CM sequences. Whereas the prevalence of cagA-encoding the CM sequence in EPIYA-AB type was 35%, CM
was present in all (100%) of the EPIYA-ABC and EPIYA-AB’C (EPIYT) genotypes characterized here (Table 5).

Discussion

County-wide sampling indicates a prevalence of carriage of H. pylori by asymptomatic Thais of ~44%, based on
fecal examination41, with marginally higher sero-prevalence45. This report describes an association between infection with the fish-borne liver fluke O. viverrini and carriage of species of Helicobacter in opisthorchiasis-endemic
northeastern Thailand. H. pylori represented the major species of Helicobacter but, in addition, H. bilis and mixed
H. pylori/H. bilis infection occurred more often during active opisthorchiasis than in uninfected or lightly infected
persons, in turn confirming earlier reports46,47. Mixed infection with H. pylori and H. bilis may be associated with
more severe hepatobiliary disease. Prevalence of H. pylori and H. bilis also was elevated in participants who were
heavily infected with O. viverrini. Opisthorchiasis appeared to exacerbate severity of H. pylori/H. bilis-associated
disease in like fashion to infections in hamsters35,37, confirming an association between intensity of H. pylori/H.
bilis infection and presence of the liver fluke.
Prevalence of both cagA-and cagE-positive H. pylori positively correlated with increasing levels of liver fluke
infection, and prevalence of cagA-positive strains of H. pylori correlated positively with increased biliary periductal
fibrosis as diagnosed by abdominal ultrasound. The presence of cagA- and cagE-positive H. pylori strains associated with severe fibrosis, findings that suggested that H. pylori, and in particular cagA-positive strains, reached the
biliary tract, and induced hepatic inflammation that exacerbated periductal fibrosis. Discrete genotypes of cagA
associate with severity of gastrointestinal diseases48. Unclassified type (AB type) represented the major cagA genotype in this study, in contrast with earlier reports indicating that AB represents only a minority genotype carried
by otherwise healthy Thais41,49. Here, 22% of the cagA-encoded sequences were Western type (ABC type) with
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no East Asian type (ABD type), lower than reported for liver fluke infection-induced CCA44. A meta-analysis
of cagA status in Southeast Asia has revealed 51% vs. 49% of Western type and East Asian type, respectively48. There was a higher prevalence of typical Western type (EPIYA ABC) and variant AB’C type (EPIYT B)
cagA genotypes in O. viverrini-infected compared to uninfected participants.
The present findings also demonstrated that polymorphisms in cagA of H. pylori circulate among Thais with
opisthorchiasis. For the ABC and AB’C type CagA, there was a higher frequency of the deduced 16-amino-acid
CagA multimerization (CM) types during liver fluke infection. CM is conserved between Western CagA and East
Asian CagA50, although Western type CagA invariably exhibits the CM sequence39. The CM sequence represents
a membrane-targeting signal50, which interacts with PAR1b, thus inducing junctional and polarity defects29,50,51.
Notably, the PCR primers employed here spanned the entire 3′-region of cagA encoding the multimers of the
tyrosine phosphorylation motifs52,53. Structural polymorphism in the CM reflects the degree of virulence of
CagA54. Here infection with any CagA type H. pylori bearing CM sequences was associated with severe hepatobiliary disease, with an odds ratio up as high as 38. This characterization of sequences with both EPIYA-C/D
motif and CM sequence suggested increased phosphorylation motifs capable of provoking pronounced disease54.
Phylogenetic analysis revealed four discrete clades, and all four differed from the from typical Western and East
Asian CagA types including those associating with Western CCA sequences44. Although the Thai CagA sequences
were separated from the pathogenic reference sequences, opisthorchiasis might be involved in the various novel
types of CagA (with CM sequence), which associates with severe disease. Accordingly, we hypothesize that not
only is the liver fluke O. viverrini a reservoir of Helicobacter but also a selector for pathogenic strains of this
ɛ-proteobacterium. Given the elevated presence of H. pylori, and CagA including its polymorphisms with increasing intensity of liver fluke infection and biliary tract fibrosis, these new variants may, at least partly, underlie
progression of hepatobiliary disease in opisthorchiasis-endemic regions.
The International Agency for Research on Cancer of the World Health Organization classifies infection with
the liver flukes O. viverrini and Clonorchis sinensis and with H. pylori as Group 1 carcinogens4. In northern and
northeastern Thailand and Laos, infection with O. viverrini is the major risk for CCA4,8,55,56. Following initiation,
oncogenesis appears to be promoted by cholestasis and chronic inflammation. Increased mutation rates of the
tumor suppressor genes p53 and CDKN2A, and of genes encoding protein tyrosine phosphatases, SMAD4 and
others sustain cholangio-carcinogenesis, with differences between CCA induced by opisthorchiasis compared
to other risks factors57,58. As reviewed59, the release and interaction of interleukin-6, transforming growth factor
beta, tumor necrosis factor alpha, and platelet-derived growth factor are pivotal to the proliferation of cholangiocytes, while evasion of apoptosis, autonomous proliferation, and angiogenesis sustain incipient neoplasia. In parallel, infection with cagA-positive H. pylori is the major risk for gastric adenocarcinoma and mucosa associated
lymphoid tissue (MALT) lymphoma. Cellular changes following the injection of the CagA oncoprotein include
epithelial to mesenchymal transition and the hummingbird phenotype60,61, along with genetic mutations in
E-cadherin and epigenetic changes. Genome sequencing has identified driver mutations TP53, ARID1A, CDH1,
MUC6, CTNNA2, GLI3, RNF43 and others in gastric cancer62. Loss of epithelial cadherin expression from CDH1
alterations is a primary carcinogenetic incident. Cytogenetic abnormalities including the t(11; 18) (q21; q21)
translocation are frequently acquired during H. pylori-associated gastric MALT lymphoma63.
The association between opisthorchiasis and the presence of H. pylori in feces was statistically significant.
Nonetheless, direct evidence of a causal relationship where H. pylori and liver fluke infection jointly prime the
pathogenesis of hepatobiliary disease including CCA has not been obtained. It is relevant to note the outcome of
a recent study using a rodent model of human opisthorchiasis, which provides support for the association among
O. viverrini, H. pylori and biliary periductal fibrosis37,64. Liver fluke-infected hamsters were treated with antibiotics and the anthelmintic, praziquantel. Quantitative PRC analysis of tissue and organs from the hamsters indicated that the majority of the H. pylori emanated from the same sites as the liver flukes in the biliary tract given
that antibiotics failed to reduce the load of H. pylori to the baseline achieved with dual treatment with antibiotics
and praziquantel. H. pylori load in the stomach was unaffected. In addition, immunohistochemical approaches
detected H. pylori within the gut of liver flukes recovered from the hamsters.
Hepatobiliary disorders caused by Helicobacter33,44,65 can resemble opisthorchiasis42,66. Chronic lesions
ascribed to liver fluke infection, including cholangitis, biliary hyperplasia and metaplasia, periductal fibrosis and
CCA, may be due in part to Helicobacter-associated hepatobiliary disease. H. pylori DNA has been isolated from
tissues from CCA and from cholecystitis/cholelithiasis in regions endemic for opisthorchiasis33,44. Moreover, serological findings indicate infection with H. pylori in Thais at high risk for CCA65. An explanation for why infection
with the liver fluke induces bile duct cancer10 might now be clearer – involvement by H. pylori and its virulence
factors. The spiral bacilli of H. pylori attach to biliary cells, which internalize in similar fashion to their behavior
on gastric epithelium29,67. Helicobacter likely passes from the stomach to the duodenum and enters the biliary
tree through the duodenal papilla and ampulla of Vater40,67. How the microbe tolerates the neutral to alkaline pH
of the small intestine and biliary tree remains unclear17. However, an association with the migrating liver flukes
offers a plausible explanation: given that Helicobacter-like curved rods occur in the gut of O. viverrini37, and given
that the micro-environment of the O. viverrini gut is acidic, the microbe might hitchhike within the migrating
juvenile trematode. Intriguingly, glycoprotein gylcans expressed on the gut epithelium of O. viverrini68 resemble
receptors of gastric epithelial cells to which H. pylori binds69. Helicobacter may have evolved a commensalism with
O. viverrini, with conveyance into the biliary tract during the migration of the parasite following ingestion of the
metacercaria with undercooked freshwater fish35,37.
Given the elevated prevalence of CCA in regions where infection with liver fluke prevails, and given the
increasing evidence of linkage between carriage of Helicobacter during opisthorchiasis, these two biological carcinogens together may orchestrate the pathogenesis of opisthorchiasis and bile duct cancer. The association of
Helicobacter and its virulence factors, together with chronic opisthorchiasis, may underlie biliary tract disease
including CCA in liver fluke-endemic regions70. Whereas additional studies are needed to clarify this association,
Scientific Reports | 7:42744 | DOI: 10.1038/srep42744

7

www.nature.com/scientificreports/
at present detection of H. pylori in feces provides a non-invasive approach to investigate its association with biliary tract disease during opisthorchiasis.

Materials and Methods

Ethics statement. The Institutional Human Ethics Committee of Khon Kaen University approved the study,
approval number HE 551332. All methods were performed in accordance with the relevant guidelines and regulations of the committee. The participants provided written informed consent following discussion with the
researchers that included information on fecal samples for laboratory analyses. All participants were adults; children were not enrolled (Table 1).

Study participants.

Participants were asked to refrain for up to 10 days from consumption of fatty foods,
antacid medication, antibiotics, anti-parasitic agents, barium, mineral oil, bismuth, or non-absorbable
anti-diarrheal agents. Patients with history of digestive-tract diseases (gastritis, gastric ulcer, cholecystitis, cholangitis, cholecystectomy, others) were excluded from the study. A total of 553 participants provided stool samples;
260 were parasitologically negative for fecal eggs of O. viverrini and 293 were egg-positive for O. viverrini from
age-sex matched residents of villages in four provinces of the opisthorchiasis-endemic Isaan region of northeastern Thailand1,8,42,71. In particular, those enrolled included 273, 107, 93 and 80 people from the provinces of Khon
Kaen, Roi-et, Mahasarakham and Kalasin, respectively (Supplementary Figure S2). The participants included 288
females and 265 males, aged 30 to 70 years (Table 1).

Parasitological diagnosis of infection with the liver fluke Opisthorchis viverrini.

Parasitological
diagnosis of opisthorchiasis was accomplished using formalin-ethyl acetate concentration of one gram of feces,
followed by light microscopy examination of the concentrate72. The method is suitable for diagnosis of O. viverrini
eggs and widely employed for diagnosis of opisthorchiasis72. Thereafter, participants were grouped according to
fecal egg count, i.e. intensity of infection into five categories: 1) EPG (eggs per gram of feces) = 0 [i.e. uninfected];
2) 1–100 EPG; 3) 101–500 EPG; 4) 501–1,000 EPG; and 5) >1,000 EPG. There were 260, 193, 73, 12 and 15 participants in these five categories, respectively (Table 2).

Detection by PCR of Helicobacter species and virulence genes. DNA was isolated from about one

gram of feces, stored in 70% ethanol, using a QIAamp DNA Stool Mini Kit (Qiagen, Germany) with concentrations ranging from 50 to 500 ng/μl, and total yields of 2 to 15 μg. Subsequently, 50 ng DNA from the samples
served as the template for PCR performed in a GeneAmp PCR system 9700, Applied Biosystems thermal cycler;
the reaction mixture included 1x Gotaq Colorless Master Mix (Promega) containing 0·2 mM dNTP, 1·5 mM
MgCl2, 1·25 U Tag DNA polymerase, with primers at 0·2 mM each. Supplementary Table S1 provides the gene
specific primers for Helicobacter species, specifically for 16 S rRNA, ureA, cagA, cagE of H. pylori, and for H. bilis
and H. hepaticus. Amplicons were sized by electrophoresis through 1·0% agarose, stained with ethidium bromide
and visualized under UV light. The expected sizes of amplicons for the 16 S rRNA, ureA (H. pylori), H. bilis,
H. hepaticus, cagA sequencing and cagE were 480, 350, 418, 405, 550–800, and 508 bp, respectively (Supplementary
Figure S3).

Abdominal ultrasonography to visualize hepatobiliary fibrosis. Abdominal scans were performed

using a mobile high-resolution ultrasound-imaging appliance (GE model LOGIQ Book XP), as described43,73.
Hepatobiliary abnormalities including periductal fibrosis in liver parenchyma, gallbladder wall, gallbladder
size, sludge, and suspected CCA (dilated intra or extrahepatic bile duct and/or liver mass) were graded and
recorded34,42. Based on the ultrasonography, grading of periductal biliary fibrosis was assigned as follows: grade
0 = absence of periportal echo(s) from all segments of liver; grade 1 = presence of periportal echo(s) in one segment of liver; grade 2 = periportal echo(s) in two to three segments; grade 3 = periportal echo(s) in more than
three segments. Status of infection with liver fluke or presence of species of Helicobacter was not known by the
radiologist during the abdominal ultrasonography.

Quantitative real-time PCR. Fecal samples from the H. pylori infected (conventional PCR ureA-positive)

participants (n = 267) used in this study were assigned to one of five groups based on fecal EPG for O. viverrini
(above): O. viverrini EPG =  0 (n =  77), EPG =  1–100 (n =  110), EPG =  101–500 (n =  57), EPG =  501–1,000 (n =  10)
and EPG >  1,000 (n = 13). In addition, feces free of H. pylori were included as a negative control37. Presence of H.
pylori was established and quantified by real time PCR using primers HpyF1: GGGTATTGAAGCGATGTTTCCT
and HpyR1: GCTTTTTTGC-CTTCGTTGATAGT 44. The quantitative real-time analysis targeted the
species-specific gene ureA of H. pylori74. DNA samples were diluted to employ equivalent template concentrations in the qPCR reactions that included 10 μl SYBR master mix (Thermo Fisher), 1 μl template-DNA, 0·5 μl of
each primer (625 nM), and 9 μl nuclease-free water. PCR was performed in triplicate (technical triplicates) in a
thermal cycler (Light Cycler 1·5, Roche), using initial denaturation at 95 °C for 9 min, followed by 40 cycles of
95 °C, 15 s, 60 °C, 60 s for the annealing and elongation steps, respectively. A 10-fold serial dilution of H. pylori
DNA was included to establish a standard curve, from 108 cells/ml to 101 cells/ml; bacterial cells were counted in
a Thoma-counting-chamber, plated and incubated for subsequent extraction of DNA. E. coli DNA served as the
negative control74.

Phylogenetic analysis of cagA gene partial sequences. To establish phylogenetic relationships among

the H. pylori genotypes, 62 participants infected and 13 uninfected with O. viverrini were investigated. Partial
sequences of cagA genes amplified by PCR were sequenced by the Sanger approach (First BASE Laboratories,
Malaysia). In addition, sequences of Western-like CagA from four references were analyzed: Thailand (GenBank
accession BAB8742775) Western, Thailand (BAB87428) Western, Thailand (BAB87429) eastern, and Thailand
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(BAB87430) eastern. Partial, deduced amino acid sequences of CagA were searched for EPIYA motifs39,44 using
the ExPASy-Translate software followed by multiple sequence alignment using ClustalW (Bioedit)76 with further
editing using GeneDoc (http://www.nrbsc.org/gfx/genedoc/ebinet.htm). Evolutionary history was inferred using
Neighbor-Joining77. A bootstrapped consensus tree inferred from 500 replicates was taken to represent the evolutionary history of the taxa analyzed. Branches corresponding to partitions reproduced in less than 50% bootstrap
replicates were collapsed. Evolutionary distances were computed using the JTT matrix-based method78 and the
units represent the number of amino acid substitutions per site. The analysis of cagA included 82 deduced amino
acid residues; positions containing gaps or missing data were eliminated, leaving 61 positions in the final dataset.
Phylogenetic analyses were conducted with MEGA579.

Statistical analysis.

Both univariate and multivariate analyses were employed. Participants were categorized according to the intensity of infection with O. viverrini, i.e. EPG = 0, 1 to 100, 101 to 500, 501 to 1,000, and
>1,000. The findings are presented in a box and whisker plot, and means of total bacterial cell counts per gram
of feces according to intensity of infection with O. viverrini were compared using a one-way analysis of variance
(ANOVA) (post hoc test.
χ2 tests were performed to determine the relationship between intensity of infection with O. viverrini and
prevalence of Helicobacter. Measures of Helicobacter infection included PCR-positivity for the presence of the
16 S rRNA gene, ureA, cagA, cagA genotype, cagE, mixed cagA and cagE, H. bilis, H. hepaticus, and H. pylori +  H.
hepaticus. χ2 tests for trend were used to investigate the effect of increasing level of liver fluke infection and each
parameter of infection with species of Helicobacter.
Age and sex adjusted relative risk ratios (RRR) and 95% confidence intervals (CIs) for presence or absence of
Helicobacter infection, and association with hepatobiliary disease were determined using age and sex adjusted
multinomial logistic regression analyses. Ordinal logistic regression was performed to determine overall odds
ratios for each model; these were only presented if the proportional odds assumption was met for a given mode.
Statistical tests were two-sided, and were performed using IBM SPSS Statistics, IBM Corp., NY, 2 ×  2 Contingency
Table online calculator, VassarStats, and STATA version 10, College Station, TX. P ≤ 0·05 was considered statistically significant.
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